Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

McCullough et al., Reviews in Cardiovascular Medicine, doi:10.31083/j.rcm.2020.04.264
Dec 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 412 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments. c19hcq.org
Review urging early treatment of COVID-19 with sequential multidrug treatment that has been shown to be safe and effective. Proposed treatment includes zinc, vitamin D & C, quercetin, and depending on age, comorbidities, and symptoms may include >=2 of HCQ, ivermectin, favipiravir; AZM/DOXY; corticosteroids; colchicine; bamlanivimab; aspirin; LMWH; and supplemental oxygen.
Review covers zinc, vitamin D, ivermectin, and HCQ.
McCullough et al., 30 Dec 2020, peer-reviewed, 58 authors.
This PaperHCQAll
Abstract: Published online: December 30, 2020 Review Reviews in Cardiovascular Medicine Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) Peter A. McCullough1, * , Paul E. Alexander2 , Robin Armstrong3 , Cristian Arvinte4 , Alan F. Bain5 , Richard P. Bartlett6 , Robert L. Berkowitz7 , Andrew C. Berry8 , Thomas J. Borody9 , Joseph H. Brewer10 , Adam M. Brufsky11 , Teryn Clarke12 , Roland Derwand13 , Alieta Eck14 , John Eck14 , Richard A. Eisner15 , George C. Fareed16 , Angelina Farella17 , Silvia N. S. Fonseca18 , Charles E. Geyer, Jr.19 , Russell S. Gonnering20 , Karladine E. Graves21 , Kenneth B. V. Gross22 , Sabine Hazan23 , Kristin S. Held24 , H. Thomas Hight25 , Stella Immanuel26 , Michael M. Jacobs27 , Joseph A. Ladapo28 , Lionel H. Lee29 , John Littell30 , Ivette Lozano31 , Harpal S. Mangat32 , Ben Marble33 , John E. McKinnon34 , Lee D. Merritt35 , Jane M. Orient36 , Ramin Oskoui37 , Donald C. Pompan38 , Brian C. Procter39 , Chad Prodromos40 , Juliana Cepelowicz Rajter41 , Jean-Jacques Rajter41 , C. Venkata S. Ram42 , Salete S. Rios43 , Harvey A. Risch44 , Michael J. A. Robb45 , Molly Rutherford46 , Martin Scholz47 , Marilyn M. Singleton48 , James A. Tumlin49 , Brian M. Tyson50 , Richard G. Urso51 , Kelly Victory52 , Elizabeth Lee Vliet53 , Craig M. Wax54 , Alexandre G. Wolkoff55 , Vicki Wooll56 and Vladimir Zelenko57 1 Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, 75226, TX, USA Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, L8S 4L8, Ontario, Canada Armstrong Medical Group, Texas City, 75510, TX, USA 4 North Suburban Medical Center and Vibra Hospital, Thornton, 80229, Colorado, USA 5 Chicago Health and Wellness Alliance, Chicago, 60603, IL, USA 6 Recipient of the Texas HHS Meritorious Service Award, 78751, Texas, USA 7 PianoPsych, LLC, Natick, 01760, MA, USA 8 Division of Gastroenterology, Department of Medicine, Larkin Community Hospital, S. Miami, 33143, FL, USA 9 Centre for Digestive Diseases, Five Dock, 2046, NSW, Australia 10 Infectious Diseases, St. Luke's Hospital, Kansas City, 64111, MO, USA 11 University of Pittsburgh, Department of Medicine, Pittsburgh, 15213, PA, USA 12 Clarke Neurology, Newport Beach, 92660, CA, USA 13 Alexion Pharma Germany GmbH, 80687, Munich, Germany 14 Affordable Health, Inc., Piscataway, 08854, NJ, USA 15 Eisner Laser Center, Macon, 31210, GA, USA 16 Pioneers Medical Center, Brawley, 92227, CA, USA 17 Privia Medical Group, Webster, 24510, TX, USA 18 Hapvida HMO, Ribeirão Preto,14015-130, SP, Brazil 19 Houston Methodist Cancer Center, Houston, 77030, TX, USA 20 The Medical College Of Wisconsin, Milwaukee, 53226, WI, USA 21 Personal Healthcare Network, Kansas City, 64116, MO, USA 22 Fusion Clinical Multimedia, Inc., Philadelphia, 19019, PA, USA 23 Ventura Clinical Trials, PROGENABIOME, Malibu Specialty Center, Ventura, 93003, CA, USA 24 Stone Oak Ophthalmology, Immediate Past President, Association of American Physicians and Surgeons, San Antonio, 78258, TX , USA 25 Cardiosound, Atlanta, 30342, GA, USA 26 Rehoboth Medical Center, Houston, 77083, TX, USA 27 Complex Primary Care Medicine, Pensacola, 32507, FL, USA 28 University of California Los Angeles, Los Angeles, 90095, CA, USA 29 Emergency Medicine, Phoenix, 85016, AZ, USA 30 Family Medicine, Kissimmee, 34741, FL, USA 31 Lozano Medical Clinic,..
{ 'indexed': {'date-parts': [[2024, 4, 28]], 'date-time': '2024-04-28T22:32:32Z', 'timestamp': 1714343552083}, 'reference-count': 0, 'publisher': 'IMR Press', 'issue': '4', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020]]}, 'DOI': '10.31083/j.rcm.2020.04.264', 'type': 'journal-article', 'created': { 'date-parts': [[2020, 12, 30]], 'date-time': '2020-12-30T09:45:31Z', 'timestamp': 1609321531000}, 'page': '517', 'source': 'Crossref', 'is-referenced-by-count': 52, 'title': 'Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk ' 'SARS-CoV-2 infection (COVID-19)', 'prefix': '10.31083', 'volume': '21', 'member': '16242', 'container-title': 'Reviews in Cardiovascular Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://rcm.imrpress.com/fileup/2153-8174/PDF/1609227825483-1867379003.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 1, 31]], 'date-time': '2022-01-31T19:48:39Z', 'timestamp': 1643658519000}, 'score': 1, 'resource': {'primary': {'URL': 'https://imrpress.com/journal/RCM/21/4/10.31083/j.rcm.2020.04.264'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020]]}, 'references-count': 0, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2020]]}}, 'URL': 'http://dx.doi.org/10.31083/j.rcm.2020.04.264', 'relation': {}, 'ISSN': ['2153-8174'], 'subject': [], 'container-title-short': 'Reviews in Cardiovascular Medicine', 'published': {'date-parts': [[2020]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit